Literature DB >> 458830

Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetase.

J M Lamon, B C Frykholm, D P Tschudy.   

Abstract

Acute intermittent porphyria (AIP) is a primary disorder of haem biosynthesis that is chemically characterised by raised urinary porphobilinogen (PBG). A defect in the biochemical pathway at the step of PBG conversion to uroporphyrinogen has been shown to be a result of a partial deficiency of the enzyme uroporphyrinogen I synthetase (uro I syn). The ascertainment rate of latent AIP (that is, chemically manifest but clinically asymptomatic) was examined in 185 individuals from 12 AIP kindreds using three parameters: red cell uro I syn, quantitative urinary PBG, and pedigree analysis with respect to uro I syn. Approximately 80% of individuals could be assigned as normal or latent AIP on the basis of the uro I syn assay alone. The remaining 20% could not be assigned because of an intermediate range of activity for the red cell assay in which the diagnosis cannot be certain. When the pedigree was used in the evaluation of the uro I syn data, the number of uncertain individuals, with respect to AIP, decreased to 10%. The enzyme method detected latent AIP in 37.5% of blood relatives, whereas quantitative urinary PBG alone detected only 15.2%. The pattern of inheritance for the uro I syn deficiency is consistent with Mendelian dominant inheritance, and it is likely that it is the basic inherited defect in AIP.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 458830      PMCID: PMC1012738          DOI: 10.1136/jmg.16.2.134

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  6 in total

Review 1.  Acute intermittent porphyria: clinical and selected research aspects.

Authors:  D P Tschudy; M Valsamis; C R Magnussen
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391

2.  Urinary delta-aminolaevulic acid and porphobilinogen in different types of porphyria.

Authors:  B HAEGER
Journal:  Lancet       Date:  1958-09-20       Impact factor: 79.321

3.  Effect of lead and genetic factors on heme biosynthesis in the human red cell.

Authors:  S Sassa; S Granick; A Kappas
Journal:  Ann N Y Acad Sci       Date:  1975-04-15       Impact factor: 5.691

4.  Porphyrin synthesis and mitochondrial respiration in acute intermittent porphyria: studies using cultured human fibroblasts.

Authors:  H L Bonkowsky; D P Tschudy; E C Weinbach; P S Ebert; J M Doherty
Journal:  J Lab Clin Med       Date:  1975-01

5.  A red cell enzyme method for the diagnosis of acute intermittent porphyria.

Authors:  C R Magnussen; J B Levine; J M Doherty; J O Cheesman; D P Tschudy
Journal:  Blood       Date:  1974-12       Impact factor: 22.113

6.  Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity.

Authors:  L J Strand; B F Felsher; A G Redeker; H S Marver
Journal:  Proc Natl Acad Sci U S A       Date:  1970-11       Impact factor: 11.205

  6 in total
  9 in total

1.  Genetic heterogeneity of the porphobilinogen deaminase gene in Swedish families with acute intermittent porphyria.

Authors:  J S Lee; G Lundin; L Lannfelt; L Forsell; C Picat; B Grandchamp; M Anvret
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

2.  The incidence of inherited porphyrias in Europe.

Authors:  George Elder; Pauline Harper; Michael Badminton; Sverre Sandberg; Jean-Charles Deybach
Journal:  J Inherit Metab Dis       Date:  2012-11-01       Impact factor: 4.982

3.  Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities.

Authors:  K E McColl; M R Moore; G G Thompson; A Goldberg
Journal:  J Med Genet       Date:  1982-08       Impact factor: 6.318

4.  Acute intermittent porphyria: identification and expression of exonic mutations in the hydroxymethylbilane synthase gene. An initiation codon missense mutation in the housekeeping transcript causes "variant acute intermittent porphyria" with normal expression of the erythroid-specific enzyme.

Authors:  C H Chen; K H Astrin; G Lee; K E Anderson; R J Desnick
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

Review 5.  Porphobilinogen deaminase gene structure and molecular defects.

Authors:  J C Deybach; H Puy
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

6.  Haplotyping of the human porphobilinogen deaminase gene in acute intermittent porphyria by polymerase chain reaction.

Authors:  J S Lee; J Lindsten; M Anvret
Journal:  Hum Genet       Date:  1990-02       Impact factor: 4.132

7.  Linkage disequilibrium between DNA polymorphisms within the porphobilinogen deaminase gene.

Authors:  G A Scobie; A J Urquhart; G H Elder; N A Kalsheker; D H Llewellyn; J Smyth; P R Harrison
Journal:  Hum Genet       Date:  1990-07       Impact factor: 4.132

Review 8.  Acute Hepatic Porphyria.

Authors:  D Montgomery Bissell; Bruce Wang
Journal:  J Clin Transl Hepatol       Date:  2015-03-15

Review 9.  Clinically important features of porphyrin and heme metabolism and the porphyrias.

Authors:  Siddesh Besur; Wehong Hou; Paul Schmeltzer; Herbert L Bonkovsky
Journal:  Metabolites       Date:  2014-11-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.